Home > Drug List > Niraparib > Drug interactions of Niraparib

Drug interactions of Niraparib

Potent CYP3A4 Inhibitors

If co-administration is necessary, the dosage of revumenib should be reduced.

Potent or Moderate CYP3A4 InducersCo-administration with revumenib is not recommended.

Drugs That Prolong QTc Interval

Co-administration with revumenib is not recommended. If co-administration is unavoidable, more frequent monitoring for QTc interval prolongation in patients is required.

FDA，2025.10